Talk:Assessment of the health impacts of H1N1 vaccination/Group C
From Testiwiki
< Talk:Assessment of the health impacts of H1N1 vaccination
Revision as of 14:15, 4 April 2011 by Jpmannikko (talk | contribs) (→Pandemrix should not be used because of narcolepsy risk)
Pandemrix should not be used because of narcolepsy risk
Jukka-Pekka, Kati?
Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
Argumentation:
⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST)
←3 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)
←6 : There have been claims that THL would have had a conflict of interest, as it had received financing worth EUR 6 million from the vaccine producer GalaxoSmithKline (GSK) --Jpmannikko 16:51, 4 April 2011 (EEST)
|